Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.

@article{Wei2013PerioperativeAT,
  title={Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.},
  author={Qiang Wei and Xiao Fang Xu and Q H Ling and Bo Zhou and Shu-sen Zheng},
  journal={Hepatobiliary & pancreatic diseases international : HBPD INT},
  year={2013},
  volume={12 3},
  pages={251-5}
}
BACKGROUND After effective treatment with antiviral agent, patients with low serum hepatitis B virus (HBV) DNA level had a low incidence of hepatocellular carcinoma (HCC). HBV reactivation after HCC surgery is associated with HCC recurrence. To date, there are no universal guidelines for the perioperative antiviral treatment of patients with chronic hepatitis B, let alone antiviral therapy in patients with HBV-related HCC. The present analysis is trying to develop a perioperative anti-HBV… CONTINUE READING